Literature DB >> 25868666

Amyloidosis in alkaptonuria.

Lia Millucci1, Daniela Braconi, Giulia Bernardini, Pietro Lupetti, Josef Rovensky, Lakshminaryan Ranganath, Annalisa Santucci.   

Abstract

Alkaptonuria (AKU) is an ultra-rare inborn error of metabolism developed from the lack of homogentisic acid oxidase activity, causing homogentisic acid (HGA) accumulation that produces an HGA-melanin ochronotic pigment, of hitherto unknown composition. Besides the accumulation of HGA, the potential role and presence of unidentified proteins has been hypothesized as additional causal factors involved in ochronotic pigment deposition. Evidence has been provided on the presence of serum amyloid A (SAA) in several AKU tissues, which allowed classifying AKU as a novel secondary amyloidosis. In this paper, we will briefly review all direct and indirect lines of evidence related to the presence of amyloidosis in AKU. We also report the first data on abnormal SAA serum levels in a cohort of AKU patients.

Entities:  

Mesh:

Year:  2015        PMID: 25868666     DOI: 10.1007/s10545-015-9842-8

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  50 in total

1.  Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.

Authors:  Laura Tinti; Adriano Spreafico; Daniela Braconi; Lia Millucci; Giulia Bernardini; Federico Chellini; Giovanni Cavallo; Enrico Selvi; Mauro Galeazzi; Roberto Marcolongo; James A Gallagher; Annalisa Santucci
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

2.  Chondrocyte of rheumatoid arthritis serve as a source of intra-articular acute-phase serum amyloid A protein.

Authors:  Shigeki Momohara; Hiroshi Okamoto; Hisashi Yamanaka
Journal:  Clin Chim Acta       Date:  2008-08-05       Impact factor: 3.786

Review 3.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

Authors:  D Allan Butterfield; Christopher M Lauderback
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

Review 4.  [Parkinson disease and alkaptonuria: fortuitous association or striatonigral ochronosis?].

Authors:  R Aquaron; G Fayet; C Barthet; S Désiré; F Viallet
Journal:  Rev Neurol (Paris)       Date:  1995-01       Impact factor: 2.607

5.  Interferences of homogentisic acid (HGA) on routine clinical chemistry assays in serum and urine and the implications for biochemical monitoring of patients with alkaptonuria.

Authors:  S L Curtis; N B Roberts; L R Ranganath
Journal:  Clin Biochem       Date:  2013-12-27       Impact factor: 3.281

Review 6.  Oxidative stress and mechanisms of ochronosis in alkaptonuria.

Authors:  Daniela Braconi; Lia Millucci; Giulia Bernardini; Annalisa Santucci
Journal:  Free Radic Biol Med       Date:  2015-02-28       Impact factor: 7.376

Review 7.  Redox proteomics gives insights into the role of oxidative stress in alkaptonuria.

Authors:  Daniela Braconi; Lia Millucci; Lorenzo Ghezzi; Annalisa Santucci
Journal:  Expert Rev Proteomics       Date:  2013-12       Impact factor: 3.940

8.  Functional amyloid formation within mammalian tissue.

Authors:  Douglas M Fowler; Atanas V Koulov; Christelle Alory-Jost; Michael S Marks; William E Balch; Jeffery W Kelly
Journal:  PLoS Biol       Date:  2006-01       Impact factor: 8.029

9.  Diagnosis of secondary amyloidosis in alkaptonuria.

Authors:  Lia Millucci; Lorenzo Ghezzi; Giulia Bernardini; Daniela Braconi; Pietro Lupetti; Federico Perfetto; Maurizio Orlandini; Annalisa Santucci
Journal:  Diagn Pathol       Date:  2014-09-26       Impact factor: 2.644

10.  Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.

Authors:  Giulia Bernardini; Marcella Laschi; Michela Geminiani; Daniela Braconi; Elisa Vannuccini; Pietro Lupetti; Fabrizio Manetti; Lia Millucci; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2015-03-12       Impact factor: 4.982

View more
  8 in total

Review 1.  Acute fatal metabolic complications in alkaptonuria.

Authors:  A S Davison; A M Milan; J A Gallagher; L R Ranganath
Journal:  J Inherit Metab Dis       Date:  2015-11-23       Impact factor: 4.982

2.  Angiogenesis in alkaptonuria.

Authors:  Lia Millucci; Giulia Bernardini; Barbara Marzocchi; Daniela Braconi; Michela Geminiani; Silvia Gambassi; Marcella Laschi; Bruno Frediani; Federico Galvagni; Maurizio Orlandini; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2016-09-26       Impact factor: 4.982

3.  An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases.

Authors:  Giacomina Brunetti; Gabriele D'Amato; Mariangela Chiarito; Apollonia Tullo; Graziana Colaianni; Silvia Colucci; Maria Grano; Maria Felicia Faienza
Journal:  World J Pediatr       Date:  2018-10-20       Impact factor: 2.764

4.  Quick Diagnosis of Alkaptonuria by Homogentisic Acid Determination in Urine Paper Spots.

Authors:  Gabriella Jacomelli; Vanna Micheli; Giulia Bernardini; Lia Millucci; Annalisa Santucci
Journal:  JIMD Rep       Date:  2016-04-14

5.  Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease.

Authors:  Vittoria Cicaloni; Ottavia Spiga; Giovanna Maria Dimitri; Rebecca Maiocchi; Lia Millucci; Daniela Giustarini; Giulia Bernardini; Andrea Bernini; Barbara Marzocchi; Daniela Braconi; Annalisa Santucci
Journal:  FASEB J       Date:  2019-08-28       Impact factor: 5.834

6.  Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.

Authors:  Juliette H Hughes; Ke Liu; Antonius Plagge; Peter J M Wilson; Hazel Sutherland; Brendan P Norman; Andrew T Hughes; Craig M Keenan; Anna M Milan; Takao Sakai; Lakshminarayan R Ranganath; James A Gallagher; George Bou-Gharios
Journal:  Hum Mol Genet       Date:  2019-12-01       Impact factor: 6.150

7.  Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease.

Authors:  Ottavia Spiga; Vittoria Cicaloni; Cosimo Fiorini; Alfonso Trezza; Anna Visibelli; Lia Millucci; Giulia Bernardini; Andrea Bernini; Barbara Marzocchi; Daniela Braconi; Filippo Prischi; Annalisa Santucci
Journal:  Orphanet J Rare Dis       Date:  2020-02-12       Impact factor: 4.123

Review 8.  Alkaptonuria: Current Perspectives.

Authors:  Andrea Zatkova; Lakshminarayan Ranganath; Ludevit Kadasi
Journal:  Appl Clin Genet       Date:  2020-01-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.